Showing results (141-150 of 219) with videos related to
Sort By:
Pageof 22
Scientific Data|May 14, 2024
ReMIND: The Brain Resection Multimodal Imaging DatabaseParikshit Juvekar, Reuben Dorent, Fryderyk Kögl, et al.Medrxiv : the Preprint Server for Health Sciences|September 25, 2023
ReMIND: The Brain Resection Multimodal Imaging DatabaseParikshit Juvekar, Reuben Dorent, Fryderyk Kögl, et al.Neuro-Oncology|August 2, 2024
RNA splicing as a biomarker and phenotypic driver of meningioma DNA-methylation groupsNathan K Leclair, Abrar Choudury, William C Chen, et al.Journal of Neuro-Oncology|January 4, 2021
Predictors of postoperative biochemical remission in acromegalyShun Yao, Wen-Li Chen, Sherwin Tavakol, et al.Neuro-Oncology|October 13, 2022
Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical featuresAbrar Choudhury, William C Chen, Calixto-Hope G Lucas, et al.Neurosurgery Practice|November 7, 2025
Reassessing the Management of Treatment-Induced Brain Necrosis in Metastatic Patients: Advancing Surgical Alternatives to Steroid TherapyJoshua D Bernstock, Nicholas B Dadario, Pablo A Valdés, et al.Nature Genetics|June 10, 2022
SMARCE1 deficiency generates a targetable mSWI/SNF dependency in clear cell meningiomaRoodolph St Pierre, Clayton K Collings, Daniel D Samé Guerra, et al.Neuro-Oncology|August 24, 2018
Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working GroupRaymond Y Huang, Wenya Linda Bi, Michael Weller, et al.Neuro-Oncology|April 27, 2017
Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based studyDaniel N Cagney, Allison M Martin, Paul J Catalano, et al.Neuro-Oncology|February 11, 2026
The prognostic impact of CDKN2A/B hemizygous deletions in meningiomaFranziska M Ippen, Thomas Hielscher, Areeba Patel, et al.Pageof 22